SP
Sun Pharma Advanced Research Company Limited
SPARC.NS · NSE
₹199.47 -1.52% (-₹3.07)
1M -6.44%
Market Cap ₹65.5B
P/E Ratio 4.14x
Div. Yield -
ROE 318.71%
Bulios Fair Price
₹295.09
47.9% upside
Trenutna cena
₹199.47
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SPARC.NS trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
83 /100
Cheap P/S 3.43x
P/E 4.14x
P/B 4.89x
Growth
100 /100
Growing Book val. growth 37.70%
Rev. growth 98.91%
FCF growth N/A
Profitability
70 /100
Strong Op. margin 84.17%
Gross margin 93.29%
FCF margin 7.28%
Quality
100 /100
Excellent ROE 318.71%
Asset turnover N/A
ROIC N/A
Debt
100 /100
Low Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Int. coverage 44.21x
Stability
28 /100
Unstable EPS volatility 333.03%
Beta 0.66x
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SPARC.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Anilkumar Raghavan
Employees
279
Headquarters
Mumbai